Invention Grant
- Patent Title: Bicyclic PKM2 activators
-
Application No.: US15645621Application Date: 2017-07-10
-
Publication No.: US10087169B2Publication Date: 2018-10-02
- Inventor: Francesco G. Salituro , Jeffrey O. Saunders
- Applicant: Agios Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Agios Pharmaceuticals, Inc.
- Current Assignee: Agios Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Goodwin Procter LLP
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D265/18 ; C07D265/36
Abstract:
Compounds and compositions comprising compounds that activate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that activate PKM2 in the treatment of cancer.
Public/Granted literature
- US20170369481A1 Bicyclic PKM2 Activators Public/Granted day:2017-12-28
Information query
